Knowledge Graph

Graph explorer

Search resolved entities, walk their edges, and read the sentence behind every one.

Entities25 of 207,987

Entity

Velaris Therapeutics, Inc.

organization1 mentionslast seen Oct 13, 2026

Biopharmaceutical company focused on pulmonary hypertension therapies, acquired by Alaunos.

Relationships 8

Velaris Therapeutics, Inc.

Relationship

Velaris Therapeutics, Inc.partners withParagon Laboratories, Inc.

90% confidence1 supporting mentionsfrom Oct 13, 2026

Either name opens that entity’s relationships.

Sources 1

filingSEC EDGAROct 13, 2026Alaunos Therapeutics, Inc. 8-K: Item 1.01: Entry into a Material Definitive Agreement; Item 2.01: Completion of Acquisition or Disposition of Assets; Item 3.02: Unregistered Sales of Equity Securities; Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Item 7.01: Regulation FD Disclosure; Item 9.01: Financial Statements and Exhibits
Velaris entered into a Fusion Protein Discovery and Option Agreement (the "ADOA") with Paragon Laboratories, Inc. ("Paragon") pursuant to which Paragon will conduct research programs